268 related articles for article (PubMed ID: 34895065)
1. Long noncoding RNA matrilineal expression gene 3 inhibits hepatocellular carcinoma progression by targeting microRNA-5195-3p and regulating the expression of forkhead box O1.
Li M; Liao H; Wu J; Chen B; Pang R; Huang J; Zhu Y
Bioengineered; 2021 Dec; 12(2):12880-12890. PubMed ID: 34895065
[TBL] [Abstract][Full Text] [Related]
2. High glucose regulates ERp29 in hepatocellular carcinoma by LncRNA MEG3-miRNA 483-3p pathway.
Li X; Cheng T; He Y; Zhou S; Wang Y; Zhang K; Yu P
Life Sci; 2019 Sep; 232():116602. PubMed ID: 31251997
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA 02027 inhibits proliferation, migration and invasion of hepatocellular carcinoma via miR-625-3p/PDLIM5 pathway.
Wang J; Zhu Y; Ai X; Wan H; Jia W; Chu J; Xu B; Kong X; Kong L
J Gene Med; 2023 Jun; 25(6):e3485. PubMed ID: 36811210
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
Liu Z; Ouyang G; Lu W; Zhang H
Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
[TBL] [Abstract][Full Text] [Related]
6. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
Guo X; Wang Y
Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
[TBL] [Abstract][Full Text] [Related]
7. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11.
Liu Z; Chen JY; Zhong Y; Xie L; Li JS
Braz J Med Biol Res; 2019; 52(10):e8631. PubMed ID: 31531526
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
Zhou Q; Zhang W; Wang Z; Liu S
BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA
Gong X; Zhu Z
Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
[No Abstract] [Full Text] [Related]
10. ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1.
Pan G; Zhang J; You F; Cui T; Luo P; Wang S; Li X; Yuan Q
Bioengineered; 2022 Jan; 13(1):1346-1358. PubMed ID: 34983308
[TBL] [Abstract][Full Text] [Related]
11. Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis.
Liu Y; Liu J; Cui J; Zhong R; Sun G
Bioengineered; 2022 Jan; 13(1):1115-1125. PubMed ID: 34978464
[TBL] [Abstract][Full Text] [Related]
12. LINC01018 confers a novel tumor suppressor role in hepatocellular carcinoma through sponging microRNA-182-5p.
Wang S; Xu M; Sun Z; Yu X; Deng Y; Chang H
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G116-G126. PubMed ID: 31021172
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
[TBL] [Abstract][Full Text] [Related]
14. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
[TBL] [Abstract][Full Text] [Related]
15. lncRNA-SNHG15 accelerates the development of hepatocellular carcinoma by targeting miR-490-3p/ histone deacetylase 2 axis.
Dai W; Dai JL; Tang MH; Ye MS; Fang S
World J Gastroenterol; 2019 Oct; 25(38):5789-5799. PubMed ID: 31636472
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG15 promotes hepatocellular carcinoma progression by sponging miR-141-3p.
Ye J; Tan L; Fu Y; Xu H; Wen L; Deng Y; Liu K
J Cell Biochem; 2019 Dec; 120(12):19775-19783. PubMed ID: 31310393
[TBL] [Abstract][Full Text] [Related]
17. MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma.
Wang Q; Yang X; Zhou X; Wu B; Zhu D; Jia W; Chu J; Wang J; Wu J; Kong L
Biochem Biophys Res Commun; 2020 Jun; 526(4):889-897. PubMed ID: 32279994
[TBL] [Abstract][Full Text] [Related]
18. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
[TBL] [Abstract][Full Text] [Related]
19. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.
Gao W; Chen X; Chi W; Xue M
Int J Mol Med; 2020 Nov; 46(5):1743-1754. PubMed ID: 33000222
[TBL] [Abstract][Full Text] [Related]
20. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]